Diagnostics & Healthcare News
Axonics Receives CE Mark for Sacral Neuromodulation External Trial System
Axonics Modulation Technologies, Inc., developer of the first rechargeable Sacral Neuromodulation (r-SNM™) system for the treatment of urinary and bowel dysfunction, announced today that it has received the CE mark for its Sacral Neuromodulation External Trial System. Axonics received CE mark in June 2016 for...